Drug Topics

SEPTEMBER 5, 2023

The 2023 Healthcare Advocate Summit is September 5 to 9 in New Orleans, Louisiana.

281

281

PharmaVoice

SEPTEMBER 5, 2023

Leaked data for Roche’s immunotherapy appeared positive, but some experts aren’t convinced it’ll make an impact for cancer patients.

264

264

Drug Topics

SEPTEMBER 5, 2023

Your weekly roundup of the latest news from Drug Topics®.

281

281

PharmaVoice

SEPTEMBER 5, 2023

Explore four modern tech capabilities designed to help decrease cycle times, improve processes and compliance and mitigate site burdens.

246

246

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

Drug Topics

SEPTEMBER 5, 2023

The majority of persistent irAEs were hypothyroid, adrenal insufficiency, arthritis, dermatitis or pruritis, and hypophysitis.

Immunization 247

Immunization 247

STAT

SEPTEMBER 5, 2023

University of California graduate students were thrilled last December when they won what they thought were big pay increases after an unprecedented strike. Most of them could expect a 10% salary increase the first year of the new three-year contract, the university system said. But students contend it hasn’t worked out that way. Graduate students on some of the academic system’s 10 campuses are accusing their universities of wage theft, claiming they’re using sleight of han

Documentation 144

Documentation 144

STAT

SEPTEMBER 5, 2023

Health care leaders and technology companies are investing heavily in large language models, a powerful class of deep learning models that are trained on vast troves of data. But while enthusiasm for generative AI is high and research is booming, it’s just starting to gain a toehold in clinical settings. Generative AI could be a revolution in health care — but along the way, it will have to address concerns about whether tools meet standards of safety, privacy, equity, and practica

Hospitals 141

Hospitals 141

Pharmacy Times

SEPTEMBER 5, 2023

This year's survey features questions focused on compensation, fulfillment, and burnout.

132

132

STAT

SEPTEMBER 5, 2023

The world’s largest technology companies are racing to build generative AI into every corner of health and medicine. Microsoft has formed an alliance with the electronic health records vendor Epic to wire the technology into dozens of health software products. Google is infusing it into tools used by hospitals to collect and organize data on millions of patients.

Hospitals 141

Hospitals 141

Fierce Healthcare

SEPTEMBER 5, 2023

Individuals appointed to positions in the Department of Health and Human Services (HHS) across the past three administrations often came from or departed for positions in the private sector, a tren | Offices like the CDC and CMS see many more appointees of different career backgrounds leaving for the private sector, a trend that researchers say deserves greater scrutiny to ensure agency decision-making is not being compromised.

125

125

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

STAT

SEPTEMBER 5, 2023

Everyone has things that, looking back, they would have done differently in the early days of 2020, had they known how the Covid-19 pandemic would tear across the globe. But those regrets may be particularly poignant for global leaders whose actions (or lack thereof) had direct impacts on how Covid-19 spread. Joanne Liu, a professor at McGill University’s School of Population and Global Health and former international president of Doctors Without Borders, has some advice for those leaders

131

131

Pharmacy Times

SEPTEMBER 5, 2023

Manufacturers must find the right balance in drug pricing, so that medications are appealing to both public and private insurers while still remaining profitable throughout their lifecycle.

Insurance 123

Insurance 123

STAT

SEPTEMBER 5, 2023

Illumina, the largest maker of DNA-sequencing technology and a storied name in the biotechnology industry, named Jacob Thaysen, a 10-year-veteran at life sciences-tools firm Agilent, as its new CEO. The appointment follows a bitter board fight that ended with the departure of Francis deSouza, who had been Illumina’s CEO since 2016. The battle, tipped off by Illumina’s troubled acquisition of cancer diagnostics firm Grail, had involved a proxy fight staged by activist investor Carl

131

131

Fierce Healthcare

SEPTEMBER 5, 2023

Self-insured employers pay more for a host of medical procedures than fully insured employers, and just why should be investigated by policymakers, according to a

Insurance 122

Insurance 122

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

STAT

SEPTEMBER 5, 2023

The recently approved RSV vaccines have been celebrated as key public health tools, but some vaccine experts have lamented one aspect of the trials that led to their approval — namely, that older adults were largely left out of them. Among adults, RSV poses the biggest threat to the oldest seniors and people with certain preexisting health conditions.

Vaccines 129

Vaccines Nursing Homes 129

Fierce Healthcare

SEPTEMBER 5, 2023

Following a discrimination lawsuit in December against Blue Cross and Blue Shield of North Carolina, the state’s largest insurer has removed 48 drugs from its costliest drug tiers. | A lawsuit against Blue Cross and Blue Shield of North Carolina appears to have prompted the insurer to backtrack and remove 48 HIV drugs from its costliest drug tiers.

Insurance 120

Insurance 120

STAT

SEPTEMBER 5, 2023

The term for a patient who lists their questions was likely coined in the late 19th century in the clinic of Jean-Martin Charcot at the Salpêtrière. Known as la maladie du petit papier , or the illness of the little paper, the derogatory descriptor was inherently feminine and usually reserved for hypochondriacs making a laundry list of their purported ailments.

Hospitals 120

Hospitals 120

Pharmaceutical Technology

SEPTEMBER 5, 2023

Nestlé has sold its peanut allergy drug Palforzia to Swiss biopharma Stallergenes Greer harma, concluding a year-long strategic review.

119

119

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

pharmaphorum

SEPTEMBER 5, 2023

UK women cleared to sue Bayer over Essure contraceptive Phil.

115

115

STAT

SEPTEMBER 5, 2023

You’re reading the web edition of STAT Health Tech, our guide to how tech is transforming the life sciences.  Sign up to get this newsletter  delivered in your inbox every Tuesday and Thursday.

Hospitals 112

Hospitals 112

Fierce Healthcare

SEPTEMBER 5, 2023

The Centers for Medicare & Medicaid Services (CMS) is partnering with states to revamp regional healthcare delivery through the AHEA | Based on care models out of Maryland, Vermont and Pennsylvania, CMS is implementing the AHEAD Model to help states address chronic disease.

112

112

pharmaphorum

SEPTEMBER 5, 2023

Is pharma market on the rebound in 2023? Mike.

111

111

Fierce Healthcare

SEPTEMBER 5, 2023

Primary care physicians who become associated with health systems more often steer their patients toward the organization’s services, increasing both utilization and care spending, according to a s | Recent study data outline physicians' tendency to point patients toward their associated health system's specialists, EDs and hospitals after joining up.

Hospitals 112

Hospitals 112

pharmaphorum

SEPTEMBER 5, 2023

Tivdak boosts survival in advanced cervical cancer Phil.

111

111

Fierce Pharma

SEPTEMBER 5, 2023

Add Novartis to the list of biopharma giants that have filed lawsuits against the U.S. government as a reaction to the Inflation Reduction Act (IRA). | Add Novartis to the list of biopharma giants that have filed lawsuits against the U.S. government as a reaction to the Inflation Reduction Act. The case was filed Friday in New Jersey federal court, three days after the CMS revealed that Novartis’ heart failure treatment Entresto was among 10 drugs subject to price negotiations in 2026.

106

106

pharmaphorum

SEPTEMBER 5, 2023

Illumina names successor to former CEO de Souza Phil.

110

110

Drug Store News

SEPTEMBER 5, 2023

According to Walmart, My Assistant has the potential to change how its associates work and solve problems.

106

106

pharmaphorum

SEPTEMBER 5, 2023

Novartis updates on Sandoz finances ahead of spin-off Phil.

105

105

Drug Store News

SEPTEMBER 5, 2023

Suppliers selected to join the portfolio are Holic Foods, Thai Culinary Arts Studio and Cafe Spice.

106

106

pharmaphorum

SEPTEMBER 5, 2023

EMA starts review of Italfarmaco's Duchenne drug Phil.

104

104

The Guardian - Pharmaceutical Industry

SEPTEMBER 5, 2023

Launch of weight-loss drug in UK helps Danish firm to market value of $428bn The success of the weightloss drug Wegovy has helped its Danish manufacturer to overtake the French luxury group LVMH as Europe’s most valuable company. After Novo Nordisk, which specialises in diabetes and weight loss treatments, launched Wegovy in the UK on Monday , its share price rose 0.7% to Danish kronor 1,310.80 ($190).

99

99

Drug Store News

SEPTEMBER 5, 2023

The donation expands food access for nearly 1,500 children in need across Lehigh, Northampton, Carbon and Wayne counties.

98

98

pharmaphorum

SEPTEMBER 5, 2023

Two Babylon Health divisions have been sold to eMed Phil.

98

98